Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease

NCT01862536 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT01862536
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01862536 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tadalafil for Pulmonary Hypertension Associated With Chronic Lung Disease
Lead sponsor
VA Office of Research and Development
Phase
Phase 2
Overall status
Completed
Start date
October 1, 2013
Completion date
August 31, 2019
Enrollment
44 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease (copd), pulmonary hypertension